Diagnostic hysteroscopy and positive peritoneal cytology in endometrial cancer: The influence of tumor molecular features.

Authors

Ran Matot, Yarden Sela, Yossi Geron, Ido Givon, Gil Zeevi, Effi Yeoshoua, Ram Eitan, Nati Bor

Published in

European journal of obstetrics, gynecology, and reproductive biology. Volume 327. Pages 115505. Oct 15, 2026. Epub Oct 15, 2026.

Abstract

To evaluate diagnostic hysteroscopy, mismatch repair (MMR) status, and p53 expression in relation to positive peritoneal cytology (PPC) in endometrial cancer.
We conducted a retrospective cohort study of women who underwent surgical staging for histologically confirmed endometrial carcinoma at a tertiary medical centre between January 2016 and December 2024. Only patients with available peritoneal cytology were included. Clinical, pathologic, and molecular data were extracted from electronic medical records. Associations between diagnostic modality, molecular characteristics, and PPC were evaluated using univariable and multivariable analyses.
A total of 212 women were included, of whom 46 (21.7 %) had PPC. Endometrioid adenocarcinoma was the predominant histological subtype (69.8 %), and most tumors were FIGO stage I-II (76.9 %). On univariable analysis, PPC was significantly associated with non-endometrioid histology, deep myometrial invasion, lymphovascular space invasion, advanced-stage disease, and abnormal p53 expression. After adjustment for age, disease stage, histological subtype, and MMR status, advanced-stage disease remained independently associated with PPC (adjusted odds ratio [aOR] 7.46, 95 % CI 2.87-19.41). Hysteroscopy-based diagnosis was not independently associated with PPC (aOR 1.67, 95 % CI 0.67--4.20). Neither MMR deficiency nor abnormal p53 expression was independently associated with cytologic positivity.
Hysteroscopy-based diagnosis was not independently associated with PPC after adjustment for clinicopathological and molecular factors. Advanced-stage disease remained independently associated with PPC. These findings add a molecular perspective to the interpretation of cytologic positivity following diagnostic hysteroscopy.

PMID:
42893677
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.